Reoxy clinical trials
The Сompany is supported by a long-standing Scientific Advisory Board which includes leading EU and UK cardiologists, hypoxia research / altitude medicine specialists, biostatisticians, and healthcare organisation experts
AI MEDIQ has a strong consortium in the field of clinically oriented medical research, including leading EU and UK research organisations, universities , clinics and professional associations such as the Heart Failure Association of the ESC, World Heart Federation and others.
11 clinical trials successfully concluded, and several are still ongoing. This proven clinical efficacy of the ReOxy treatment method places ReOxy device on the medical market.